Isolation of Candida famata from a patient with acute zonal occult outer retinopathy

Journal of Clinical Microbiology

Volumn 43, Issue 2, 2005, Pages 635-640

  Carrasco, Luis ^a   Ramos, Marta ^a   Galisteo, Rebeca ^a   Pisa, Diana ^a   Fresno, Manuel ^a   González, María Eugenia ^a,b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; VORICONAZOLE;

ACUTE ZONAL OCCULT OUTER RETINOPATHY; ADULT; ANTIGEN SPECIFICITY; ARTICLE; CANDIDA; CANDIDA FAMATA; CASE REPORT; CHRONIC DRUG ADMINISTRATION; CONJUNCTIVA; DELAYED HYPERSENSITIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXUDATE; FUNGUS ISOLATION; HUMAN; HUMAN CELL; IMMUNOLOGICAL TECHNIQUE; MALE; NONHUMAN; OPHTHALMOSCOPY; PRIORITY JOURNAL; RETINOPATHY; SKIN TEST; SYMPTOMATOLOGY; T LYMPHOCYTE; TREATMENT OUTCOME; YEAST;

ACUTE DISEASE; ANTIBODIES, FUNGAL; ANTIGENS, FUNGAL; CANDIDA; CANDIDIASIS; HUMANS; MALE; MIDDLE AGED; RETINAL DISEASES; T-LYMPHOCYTES;

CANDIDA; DEBARYOMYCES HANSENII; FUNGI;

EID: 13844298721     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.2.635-640.2005     Document Type: Article

References (54)

1. Al-Hedaithy, S. S. 2003. The yeast species causing fungemia at a univesity hospital in Riyadh, Saudi Arabia, during a 10-year period. Mycoses 46:293-298.
2. Altamura, M., D. Casale, M. Pepe, and A. Tafaro. 2001. Immune responses to fungal infections and therapeutic implications. Curr. Drug Targets Immune Endocr. Metab. Disord. 1:189-197.
3. Andrighetto, C., E. Psomas, N. Tzanetakis, G. Suzzi, and A. Lombardi. 2000. Randomly amplified polymorphic DNA (RAPD) PCR for the identification of yeasts isolated from dairy products. Lett. Appl. Microbiol. 30:5-9.
4. Andriole, V. T. 1998. Current and future therapy of invasive fungal infections. Curr. Clin. Top. Infect. Dis. 18:19-36.
5. Brown, J., Jr., and J. C. Folk. 1998. Current controversies in the white dot syndromes. Multifocal choroiditis, punctate inner choroidopathy, and the diffuse subretinal fibrosis syndrome. Ocul. Immunol. Inflamm. 6:125-127.
6. Bryan, R. G., K. B. Freund, L. A. Yannuzzi, R. F. Spaide, S. J. Huang, and D. L. Costa. 2002. Multiple evanescent white dot syndrome in patients with multifocal choroiditis. Retina 22:317-322.
7. Clemons, K. V., V. L. Calich, E. Burger, S. G. Filler, M. Grazziutti, J. Murphy, E. Roilides, A. Campa, M. R. Dias, J. E. Edwards, Jr., Y. Fu, G. Fernandes-Bordignon, A. Ibrahim, H. Katsifa, C. G. Lamaignere, L. H. Meloni-Bruneri, J. Rex, C. A. Savary, and C. Xidieh. 2000. Pathogenesis I: interactions of host cells and fungi. Med. Mycol. 38:99-111.
8. Coleman, D. C., M. G. Rinaldi, K. A. Haynes, J. H. Rex, R. C. Summerbell, E. J. Anaissie, A. Li, and D. J Sullivan. 1998. Importance of Candida species other than Candida albicans as opportunistic pathogens. Med. Mycol. 36: 156-165.
9. Dreyer, R. F., and D. J. Gass. 1984. Multifocal choroiditis and panuveitis. A syndrome that mimics ocular histoplasmosis. Arch. Ophthalmol. 102:1775-1784.
10. Garcia-Gonzalez, A., and J. L. Ochoa. 1999. Anti-inflammatory activity of Debaryomyces hansenii Cu,Zn-SOD. Arch. Med. Res. 30:69-73.
11. Gardini, F., G. Suzzi, A. Lombardi, F. Galgano, M. A. Crudele, C. Andrighetto, M. Schirone, and R. Tofalo. 2001. A survey of yeasts in traditional sausages of southern Italy. FEMS Yeast Res. 1:161-167.
12. Gass, J. D. 1993. Acute zonal occult outer retinopathy. Donders Lecture: The Netherlands Ophthalmological Society, Maastricht, Holland, June 19, 1992. J. Clin. Neuroophthalmol. 13:79-97.
13. Gass, J. D. 2003. Are acute zonal occult outer retinopathy and the white spot syndromes (AZOOR complex) specific autoimmune diseases? Am. J. Ophthalmol. 135:380-381.
14. Gass, J. D., A. Agarwal, and I. U. Scott. 2002. Acute zonal occult outer retinopathy: a long-term follow-up study. Am. J. Ophthalmol. 134:329-339.
15. Hariprasad, S. M., W. F. Mieler, E. R. Holz, H. Gao, J. E. Kim, J. Chi, and R. A. Prince. 2004. Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans. Arch. Ophthalmol. 122:42-47.
16. Helbig, H., F. Sutter, and A. Tholen. 2001. Acute zonal occult outer retinopathy (AZOOR). Ophthalmologe 98:574-578.
17. Holz, F. G., R. Y. Kim, S. D. Schwartz, C. A. Harper, J. Wroblewski, G. B. Arden, and A. C. Bird. 1994. Acute zonal occult outer retinopathy (AZOOR) associated with multifocal choroidopathy. Eye 8:77-83.
18. Ishibashi, Y. 1998. Refractory mycosis in ophthalmology. Nippon Ishinkin Gakkai Zasshi 39:211-212.
19. Jacobson, D. M. 1996. Acute zonal occult outer retinopathy and central nervous system inflammation. J. Neuroophthalmol. 16:172-177.
20. Jacobson, S. G., D. S. Morales, X. K. Sun, W. J. Feuer, A. V. Cideciyan, J. D. Gass, and A. H. Milam. 1995. Pattern of retinal dysfunction in acute zonal occult outer retinopathy. Ophthalmology 102:1187-1198.
21. Jampol, L. M., and A. Wiredu. 1995. MEWDS, MFC, PIC, AMN, AIBSE, and AZOOR: one disease or many? Retina 15:373-378.
22. Jampol, L. M., P. A. Sieving, D. Pugh, et al. 1984. Multiple evanescent white dot syndrome. I. Clinical findings. Arch. Ophthalmol. 102:671-674.
23. Kam, A. P., and J. Xu. 2002. Diversity of commensal yeasts with in and among healthy hosts. Diagn. Microbiol. Infect. Dis. 43:19-28.
24. Kawakami, S., Y. Ono, Y. Miyazawa, and H. Yamaguchi. 1998. Survey of fungemia cases during the past seventeen years at Teikyo University Hospital. Kansenshogaku Zasshi 72:105-113.
25. Krcméry, V., and A. Kunová. 2000. Candida famata fungemia in a cancer patient: case report. J. Chemother. 12:189-190.
26. Krcmèry, V., and A. J. Barnes. 2002. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J. Hosp. Infect. 50:243-260.
27. Lardenoye, C. W., A. Van der Lelij, W. S. de Loos, W. F. Treffers, and A. Rothova. 1997. Peripheral multifocal chorioretinitis: a distinct clinical entity? Ophthalmology 104:1820-1826.
28. Lee, A. G., and T. C. Prager. 1996. Acute zonal occult outer retinopathy. Acta Ophthalmol. Scand. 74:93-95.
29. Li, Y. L., S. N. Leaw, J. H. Chen, H. C. Chang, and T. C. Chang. 2003. Rapid identification of yeasts commonly found in positive blood cultures by amplification of the internal transcribed spacer regions 1 and 2. Eur. J. Clin. Microbiol. Infect. Dis. 22:693-696.
30. Mamalis, N., and M. J. Daily. 1987. Multiple evanescent white-dot syndrome. A report of eight cases. Ophthalmology 94:1209-1212.
31. Maxwell, M. J., S. A. Messer, R. J. Hollis, L. Boyken, S. Tendolkar, D. J. Diekema, and M. A. Pfaller. 2003. Evaluation of Etest method for determining fluconazole and voriconazole MICs for 279 clinical isolates of Candida species infrequently isolated from blood. J. Clin. Microbiol. 41:1087-1090.
32. Nishikawa, A., T. Sugita, and T. Shinoda. 1999. Rapid identification of Debaryomyces hansenii/Candida famata by polymerase chain reaction. Med. Mycol. 37:101-104.
33. Penk, A., and L. Pittrow. 1998. Status of fluconazole in the therapy of endogenous Candida endophthalmitis. Mycoses 41:41-44.
34. Pfaller, M. A. 1996. Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission. Clin. Infect. Dis. 22:S89-S94.
35. Pfaller, M. A., D. J. Diekema, S. A. Messer, L. Boyken, R. J. Hollis, and R. N. Jones. 2003. In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood. J. Clin. Microbiol. 41:78-83.
36. Pfaller, M. A., R. N. Jones, G. V. Doern, A. C. Fluit, J. Verhoef, H. S. Sader, S. A. Messer, A. Houston, S. Coffman, and R. J. Hollis. 1999. International surveillance of blood stream infections due to Candida species in the European Sentry Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. Diagn. Microbiol. Infect. Dis. 35:19-25.
37. Pfaller, M. A., S. A. Messer, L. Boyken, R. J. Hollis, C. Rice, S. Tendolkar, and D. J. Diekema. 2004. In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program. Diagn. Microbiol. Infect. Dis. 48:201-205.
38. Pimentel-Muiños, F. X., M. A. Muñoz-Fernández, and M. Fresno. 1994. Control of T lymphocyte activation and IL-2 receptor expression by endogenously secreted lymphokines. J. Immunol. 152:5714-5722.
39. Prinsloo, B., G. F. Weldhagen, and R. W. Blaine. 2003. Candida famata central nervous system infection. S. Afr. Med. J. 93:601-612.
40. Rao, N. A., A. V. Nerenberg, and D. J. Forster. 1991. Torulopsis candida (Candida famata) endophthalmitis simulating Propionibacterium acnes syndrome. Arch. Ophthalmol. 109:1718-1721.
41. Reis, A., R. Sundmacher, K. Tintelnot, H. Agostini, H. E. Jensen, and C. Althaus. 2000. Successful treatment of ocular invasive mould infection (fusariosis) with the new antifungal agent voriconazole. Br. J. Ophthalmol. 84: 932-933.
42. Rubio Calvo, M. C., J. Gil, I. Ramirez de Ocariz, R. Benito, and A. Rezusta. 2003. In vitro activity of fluconazole, voriconazole and posaconazole against Candida spp. Rev. Esp. Quimioter. 16:227-232.
43. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
44. Smetana, S., S. S. Feman, and C. Kleber. 2003. The retinal features of acute zonal occult outer retinopathy (AZOOR). Arch. Ophthalmol. 121:914-915.
45. Smiddy, W. E. 1998. Treatment outcomes of endogenous fungal endophthalmitis. Curr. Opin. Ophthalmol. 9:66-70.
46. St-Germain, G., and M. Leverdiere. 1986. Torulopsis candida, a new opportunistic pathogen. J. Clin. Microbiol. 24:884-885.
47. Tiedeman, J. S. 1987. Epstein-Barr viral antibodies in multifocal choroiditis and panuveitis. Am. J. Ophthalmol. 103:659-663.
48. Tsai, L., L. M. Jampol, S. Pollock, and J. Olk. 1994. Chronic recurrent multiple evanescent white dot syndrome. Retina 14:160-163.
49. Turbeville, S. D., L. D. Cowan, and J. D. Gass. 2003. Acute macular neuroretinopathy: a review of the literature. Surv. Ophthalmol. 48:1-11.
50. Verougstraete, C. 2001. White spots syndromes. Bull. Soc. Belge Ophthalmol. 279:67-78.
51. Volpe, N. J., J. R. Rizzo III, and S. Lessell. 2001. Acute idiopathic blind spot enlargement syndrome: a review of 27 new cases. Arch. Ophthalmol. 119: 59-63.
52. White, T. H., K. A. Marr, and R. A. Bowde. 1998. Clinical, cellular and molecular factors that contribute to antifungal drug resistance. Clin. Microbiol. Rev. 11:382-402.
53. Wright, R., M. Basson, L. D'Ari, and J. Rine. 1988. Increased amounts of HMG-CoA reductase induce "karmellae": a proliferation of stacked membrane pairs surrounding the yeast nucleus. J. Cell Biol. 107:101-114.
54. Yarrow, D. 1998. Methods for the isolation, maintenance and identification of yeasts, p. 77-100. In C. P. Kurtzman and J. W. Fell (ed.), The yeasts. A taxonomic study, 4th ed. Elsevier Science, Amsterdam, The Netherlands.